Nodular primary cutaneous melanoma is associated with PD-L1 expression | Zendy

Mara GiavinaBianchi | Zendy; Pedro GiavinaBianchi | Zendy; Mirian Nacagamo Sotto | Zendy; Scott J. Rodig | Zendy; Martín C. Mihm | Zendy; Cyro Festa Neto | Zendy; Lyn M. Duncan | Zendy; Jorge Kalil | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nodular primary cutaneous melanoma is associated with PD-L1 expression

Author(s) -

Mara GiavinaBianchi,

Pedro GiavinaBianchi,

Mirian Nacagamo Sotto,

Scott J. Rodig,

Martín C. Mihm,

Cyro Festa Neto,

Lyn M. Duncan,

Jorge Kalil

Publication year - 2020

Publication title -

european journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.48

H-Index - 71

eISSN - 1952-4013

pISSN - 1167-1122

DOI - 10.1684/ejd.2020.3846

Subject(s) - medicine , melanoma , phototype , tumor infiltrating lymphocytes , immunohistochemistry , cd8 , nodular melanoma , pathology , foxp3 , population , superficial spreading melanoma , adjuvant therapy , biopsy , oncology , cancer , immune system , dermatology , immunology , cancer research , environmental health

In previous studies, patients with Stage III melanomas expressing PD-L1 in more than 5% of their neoplastic cells had improved recurrence-free survival with anti-PD1 adjuvant therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research